Oxycodone is typically detectable in urine for 1 to 3 days after your last dose, though the exact window depends on the formulation, how long you’ve been taking it, and the type of test used. Blood tests have a much shorter window, while hair tests can look back up to 90 days. Here’s what determines how long it stays in your system and what each type of test can pick up.
How Your Body Processes Oxycodone
After you take a dose, oxycodone reaches peak levels in your blood within about 45 minutes to an hour. From there, your liver breaks it down into several byproducts, the most notable being noroxycodone and oxymorphone. These metabolites matter because drug tests look for them too, not just the original drug.
The elimination half-life of immediate-release oxycodone is about 3.2 hours, meaning half the drug is cleared from your blood in that time. Extended-release formulations take longer, with a half-life of roughly 4.5 hours. It generally takes four to five half-lives for a drug to leave your system almost entirely, which puts the ballpark at 16 to 23 hours for oxycodone itself to clear from your bloodstream. But metabolites linger longer than the parent drug, and that’s what extends the detection window on most tests.
Detection Windows by Test Type
Urine
Urine testing is by far the most common method, and it’s where the formulation you take makes a real difference. Immediate-release oxycodone is generally detectable for 1 to 1.5 days after a dose. Controlled-release versions stay detectable for 1.5 to 3 days because the drug is released into your system more slowly, pushing back the clearance timeline. Federal workplace drug tests use a screening cutoff of 100 ng/mL for both oxycodone and its metabolite oxymorphone, with confirmatory testing at the same threshold.
Oral Fluid (Saliva)
Saliva tests can detect oxycodone for up to 1 to 3 days. Federal testing guidelines set a lower threshold for oral fluid than for urine: the initial screening cutoff is 30 ng/mL, dropping to 15 ng/mL for confirmatory testing. That lower cutoff means saliva tests can sometimes catch trace amounts that a urine test at 100 ng/mL would miss.
Blood
Blood tests have the shortest detection window. Since oxycodone’s half-life is only a few hours, blood concentrations drop to undetectable levels within about 24 hours for most people. Blood testing is rarely used for routine screening and is more common in hospital or forensic settings.
Hair
Hair follicle testing offers the longest lookback period: up to 90 days. Head hair grows at an average rate of half an inch per month, so a standard 1.5-inch sample captures roughly three months of drug exposure. Hair tests don’t reflect what you took yesterday, though. It takes about a week or two for drug residues to become incorporated into the hair shaft and grow past the scalp.
Immediate-Release vs. Extended-Release
The difference in detection time between these two formulations comes down to how the drug enters your system. Immediate-release oxycodone dumps the full dose quickly, producing a sharp peak and faster clearance. Extended-release tablets meter the drug out gradually over 12 hours, which means your body is still absorbing new oxycodone long after someone on the immediate-release version has started clearing it. That slower absorption effectively extends the detection window by a day or more on urine tests.
Chronic Use vs. a Single Dose
If you’ve been taking oxycodone regularly over weeks or months, expect it to stay in your system longer than someone who took a single dose. Repeated dosing allows the drug and its metabolites to accumulate in body tissues. With each dose, a small reservoir builds up that takes additional time to fully clear. Someone who took one immediate-release tablet might test clean in 36 hours, while a chronic user on extended-release could still test positive at the 3-day mark or slightly beyond.
Factors That Slow Clearance
Your liver does most of the work breaking oxycodone down, so anything that affects liver function directly impacts how long the drug stays detectable. People with liver cirrhosis experience delayed gastric emptying, increased volume of distribution, and reduced blood flow through the liver, all of which slow metabolism significantly. The liver also produces proteins that bind to oxycodone in the bloodstream. When liver disease reduces those protein levels, more free drug circulates, which can both intensify effects and alter clearance patterns.
Kidney function matters too. Only about 8% to 14% of oxycodone is eliminated unchanged through the kidneys, but impaired kidney function has still been shown to increase the drug’s half-life. Metabolites that would normally be filtered out of the blood accumulate when the kidneys aren’t working efficiently, extending the detection window on urine tests.
Your genetics also play a surprisingly large role. Oxycodone is broken down primarily by two liver enzyme systems. People who carry genetic variants that make one of these enzyme pathways work faster (called ultrarapid metabolizers) produce significantly more oxymorphone, the active metabolite with 40 to 60 times greater potency at opioid receptors than oxycodone itself. Meanwhile, certain medications can interfere with the same enzymes. Taking a strong inhibitor of the main breakdown pathway can increase oxymorphone exposure by up to 3.2 times compared to normal. On the other end, drugs that speed up that enzyme pathway can dramatically reduce metabolite levels. The total range of variation in oxymorphone exposure across different genetic profiles and drug combinations spans roughly 55-fold, which is enormous.
Other factors include age (older adults generally clear drugs more slowly), body fat percentage (oxycodone is somewhat fat-soluble, so higher body fat can extend its presence), hydration levels, and overall metabolic rate.
Why Metabolites Extend the Window
Even after oxycodone itself has been eliminated, its metabolites can keep you testing positive. Oxymorphone, one of the main breakdown products, has its own half-life of 4 to 12 hours, and it’s specifically targeted on confirmatory drug tests alongside oxycodone. Noroxycodone and noroxymorphone are also produced during metabolism and can be identified on detailed lab panels. Since federal and many employer drug tests screen for both oxycodone and oxymorphone at the same cutoff level, a positive result can come from either compound still being present in your sample.